3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Interventions
pembrolizumab
81
Carboplatin
76
Magnetic Resonance Spectroscopy
73
Specimen Handling
69
Cisplatin
62
Paclitaxel
55
Gemcitabine
46
Fluorouracil
37
Dexamethasone
37
Radiation
36
Docetaxel
36
Cyclophosphamide
36
Radiotherapy
35
Pemetrexed
35
Doxorubicin
35
Oxaliplatin
33
Leucovorin
33
Bevacizumab
31
Capecitabine
28
Vincristine
27
durvalumab
26
Etoposide
24
Rituximab
23
Taxes
22
Irinotecan
22
Nivolumab
21
Letrozole
21
Prednisone
20
Biopsy
20
Platinum
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Gabapentin
×
30 days
×
Clear all
NCT06992427
2026-05-11
HOPE
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
228 enrolled